BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, February 11, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 2, 2002
View Archived Issues
Roflumilast proven safe and effective in exercise-induced asthma
Read More
Intravitreal 2-methoxyestradiol implants effective in rat model of CNV
Read More
New data on the use of thymosin beta4 in the treatment of eye wounds
Read More
Spotlight on a new type of anti-HSV drug
Read More
Basic and clinical results reported for the novel immunosuppressant FTY-720
Read More
Administration of IL-2 receptor antagonist reduces toxicities of tacrolimus
Read More
Recent data on the new immunosuppressant LF-15-0195 presented at Transplant 2002
Read More
The role of statins in organ transplantation
Read More
First launch for Neulasta in April
Read More
Injectable COX-2-specific painkiller launched for the first time
Read More
FDA approves recommended starting doses of atorvastatin
Read More
Regulatory approval sought for NMP22 BladderChek diagnostic for bladder cancer
Read More
TACE and MMP inhibitors reported by Wyeth investigators
Read More
A new series of 5-HT7 receptors and their uses disclosed by Meiji Seika
Read More
CpG-7909 enters phase I/II trial in stage IV renal cell carcinoma
Read More
Fujisawa submits NDA for antifungal micafungin
Read More
Approvable letter for Cialis in erectile dysfunction
Read More
NeuroSearch will not advance NS-3728 into phase II for sickle cell anemia
Read More
King Pharmaceuticals patents novel, potent adenosine receptor modulators
Read More
Vasomax MAA to be withdrawn in U.K.
Read More
First birth control patch Ortho Evra launched
Read More
CCR3 receptor antagonists jointly reported by Yamanouchi and Toray
Read More
Shire submits NDA for Foznol
Read More
Patient enrollment under way in Canadian phase III trials of Antegren in MS
Read More
Scientists at NeoRx identify new anticancer conjugates
Read More
FDA approves Benicar for treatment of hypertension
Read More
New series of peptide compounds synthesized at Enzyme Systems Products
Read More
